The country’s apex biomedical research regulator, the Indian Council of Medical Research, has distanced itself from a Banaras Hindu University study that raised concerns on safety of Bharat Biotech’s Covid vaccine, Covaxin, and threatened legal action against the study’s authors for acknowledging ICMR’s support for a poorly designed study without its consent. ICMR chief Rajiv Bahl has formally written to …
India is in the process of procuring at least 20 doses of monoclonal antibody from Australia to treat patients infected with the Nipah virus, Indian Council of Medical Research director general Rajiv Bahl said on Friday. “We got some doses of monoclonal antibody from the University of Queensland, Australia, in 2018 when there was an outbreak of the disease. The …
